Trump claims Tylenol use during pregnancy linked to autism, suggests Leucovorin as treatment

Group 1: Core Claims and Statements - President Trump suggested a connection between Tylenol use during pregnancy and autism, a claim disputed by many medical experts [1] - Trump stated that the FDA will notify doctors about the potential risks of Tylenol during pregnancy, although no supporting evidence was provided [2] - The FDA recently approved a version of leucovorin for a rare metabolic disorder, which may relate to neurological symptoms seen in some autism cases [3] Group 2: Industry Response - Tylenol is produced by Kenvue, which was spun off from Johnson & Johnson in 2023, and the company disagrees with the claim linking Tylenol to autism, stating it is not based in science [4] - Generic versions of acetaminophen are widely available in the market [4] Group 3: Public Health Context - The Trump administration, influenced by Health Secretary Robert F. Kennedy Jr., is under pressure to address rising autism cases in the US [4] - Broader changes to public health agencies, including the CDC, have been made, with critics noting the immunization panel's staffing includes individuals historically critical of vaccines [5]